Publication | Closed Access

Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms

NanomedicineEngineeringTherapeutic NanomaterialsMedicineNano-drug DeliveryTumor TargetingNetwork Regulatory MechanismsPharmacologyRadiation OncologyTumor MicroenvironmentHepatocellular CarcinomaTumor BiologyBiomolecular EngineeringChitosan Triptolide Nanoparticles